Changes Will Address Medical Device Clinical Trials, Regulatory Services, and Business Development
NORTH ATTLEBORO, Mass., Feb. 5 /PRNewswire/ -- MDCI, a full-service regulatory consulting firm and CRO for the medical device industry, today announced that it has named Michael Feldstein, Ph.D. to the position of vice president and principal statistician. Previously, Dr. Feldstein was vice president of clinical services. In his new role, Michael will provide high-level strategic guidance in the areas of clinical trial design and biostatistics for clients and will participate in a wide range of business development activities. Leslie Rose has been promoted to director of clinical services and is responsible for the day-to-day operations of all clinical consulting services. Vicki Anastasi has been promoted to vice president of regulatory services and business development and is responsible for the daily operations of MDCI's regulatory consulting services. She will also oversee all business development activities for the company.
"I am excited to announce these changes and promotions. Dr. Feldstein, Ms. Rose, and Ms. Anastasi have all played key roles in helping to formulate the company's growth strategy and will be instrumental in executing our business plan going forward," said Mr. William Morton, MDCI's president and founder.
About Medical Device Consultants, Inc. (MDCI)
MDCI is a full-service consulting firm and contract research organization (CRO) that helps emerging and established companies commercialize novel and innovative medical devices, diagnostics, and combination products. MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally. The company has offices in Massachusetts, California, and London. For more information, visit http://www.mdci.com
CONTACT: Lisa King, Marketing Manager of Medical Device Consultants, Inc.,
Web site: http://www.mdci.com/